Your shopping cart is currently empty

Otaplimastat HCl is a matrix metalloproteinase (MMP) inhibitor that blocks NMDA receptor-mediated excitotoxicity competitively and exhibits antioxidant activity,In oxygen-glucose-deprived endothelial cells, otaplimastat suppressed the activity rather than protein expression of MMPs by restoring the level of tissue inhibitor of metalloproteinase (TIMP) suppressed in ischemia, and consequently reduced vascular permeation. serving as a tool for research into brain ischemic injury and neuroprotection.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $483 | - | In Stock | |
| 10 mg | $691 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock | |
| 100 mg | $1,960 | - | In Stock | |
| 200 mg | $2,680 | - | In Stock |
| Description | Otaplimastat HCl is a matrix metalloproteinase (MMP) inhibitor that blocks NMDA receptor-mediated excitotoxicity competitively and exhibits antioxidant activity,In oxygen-glucose-deprived endothelial cells, otaplimastat suppressed the activity rather than protein expression of MMPs by restoring the level of tissue inhibitor of metalloproteinase (TIMP) suppressed in ischemia, and consequently reduced vascular permeation. serving as a tool for research into brain ischemic injury and neuroprotection. |
| In vitro | Otaplimastat HCl (87.5-350 μM, 20 min) can protect neuronal cells through competitive action, preventing NMDA-induced cell death [1]. Otaplimastat HCl (350 μM) is capable of inhibiting calcium ion (Ca²⁺) influx triggered by NMDA receptor activation in primary cultured neurons [1]. When pretreated for 4 hours at concentrations of 2-200 μM, Otaplimastat HCl significantly suppresses hydrogen peroxide (H₂O₂)-induced cell death and reduces reactive oxygen species (ROS) generation [2]. |
| In vivo | In the middle cerebral artery occlusion (MCAO) model, intraperitoneal injection of Otaplimastat HCl (10-20 mg/kg) (administered once 30 minutes before occlusion and once 1 hour after reperfusion) prevented ischemic neuronal death [1]. Daily intraperitoneal injection of Otaplimastat HCl (5-10 mg/kg) for 10 consecutive days alleviated stroke-induced motor function impairment [2]. |
| Synonyms | SP8203 HCl, SP 8203 HCl, Otaplimastat HCl (1176758-04-5 Free base) |
| Molecular Weight | 571.07 |
| Formula | C28H35ClN6O5 |
| Cas No. | 1176758-02-3 |
| Smiles | Cl.O=C1NC=2C=CC=CC2C(=O)N1CCCNCCCCN(C(=O)C)CCCN3C(=O)NC=4C=CC=CC4C3=O |
| Relative Density. | no data available |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.